Michal Masařík

7.8k total citations · 2 hit papers
175 papers, 6.1k citations indexed

About

Michal Masařík is a scholar working on Molecular Biology, Oncology and Nutrition and Dietetics. According to data from OpenAlex, Michal Masařík has authored 175 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Molecular Biology, 39 papers in Oncology and 39 papers in Nutrition and Dietetics. Recurrent topics in Michal Masařík's work include Trace Elements in Health (39 papers), Advanced biosensing and bioanalysis techniques (27 papers) and Cancer, Hypoxia, and Metabolism (13 papers). Michal Masařík is often cited by papers focused on Trace Elements in Health (39 papers), Advanced biosensing and bioanalysis techniques (27 papers) and Cancer, Hypoxia, and Metabolism (13 papers). Michal Masařík collaborates with scholars based in Czechia, United States and Germany. Michal Masařík's co-authors include René Kizek, Vojtěch Adam, Jaromír Gumulec, Martina Raudenská, Tomáš Eckschlager, Ondřej Zítka, Jan Balvan, Marie Stiborová, Petr Babula and Barbora Peltanová and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Michal Masařík

171 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of Metallothionein in Oxidative Stress

2013 646 citations Jaromír Gumulec, Ondřej Zítka et al. profile →
Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients

2012 524 citations Ondřej Zítka, Jaromír Gumulec et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michal Masařík Czechia	41	2.5k	1.1k	836	783	742	175	6.1k
Tomáš Eckschlager Czechia	37	3.0k 1.2×	1.2k 1.1×	1.0k 1.2×	566 0.7×	438 0.6×	158	5.9k
Shinji Oikawa Japan	48	3.0k 1.2×	532 0.5×	744 0.9×	987 1.3×	316 0.4×	157	7.3k
Yang Li China	47	4.5k 1.8×	593 0.6×	1.2k 1.4×	1.7k 2.2×	520 0.7×	276	8.1k
Ondřej Zítka Czechia	39	1.9k 0.8×	878 0.8×	270 0.3×	272 0.3×	1.1k 1.5×	205	6.0k
Yusuke Hiraku Japan	50	3.0k 1.2×	452 0.4×	1.1k 1.3×	1.2k 1.6×	380 0.5×	150	7.2k
Juanjuan Liu China	39	2.8k 1.1×	413 0.4×	539 0.6×	789 1.0×	610 0.8×	375	6.3k
Branislav Ruttkay-Nedecký Czechia	28	1.4k 0.6×	1.0k 1.0×	368 0.4×	222 0.3×	555 0.7×	80	4.6k
Weijun Qian United States	63	8.0k 3.2×	435 0.4×	790 0.9×	597 0.8×	1.4k 1.9×	312	13.3k
Jaromír Gumulec Czechia	29	1.2k 0.5×	808 0.8×	426 0.5×	387 0.5×	312 0.4×	99	3.5k
Clare L. Hawkins Australia	51	3.2k 1.3×	778 0.7×	264 0.3×	236 0.3×	424 0.6×	146	8.4k

Countries citing papers authored by Michal Masařík

Since Specialization

Citations

This map shows the geographic impact of Michal Masařík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Masařík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Masařík more than expected).

Fields of papers citing papers by Michal Masařík

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Masařík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Masařík. The network helps show where Michal Masařík may publish in the future.

Co-authorship network of co-authors of Michal Masařík

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Masařík. A scholar is included among the top collaborators of Michal Masařík based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Masařík. Michal Masařík is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vanova, Katerina Hadrava, Michal Kraus, Timothy J. Garrett, et al.. (2025). Development of succinate dehydrogenase subunit B-deficient tumor models for preclinical immunotherapy testing. Cancer Letters. 632. 217969–217969.

Navrátil, Jiří, et al.. (2025). Orchestrating movement: the role of Caveolin-1 in migration and metastasis. Molecular Cancer. 24(1). 267–267.

Vellieux, F.M.D., Kateřina Veselá, Zdeněk Kejík, et al.. (2024). Investigation of the potential effects of estrogen receptor modulators on immune checkpoint molecules. Scientific Reports. 14(1). 3043–3043. 3 indexed citations

Raudenská, Martina, et al.. (2024). Protein cargo in extracellular vesicles as the key mediator in the progression of cancer. Cell Communication and Signaling. 22(1). 25–25. 48 indexed citations

Kejík, Zdeněk, F.M.D. Vellieux, Kateřina Veselá, et al.. (2024). Cyanine dyes in the mitochondria-targeting photodynamic and photothermal therapy. Communications Chemistry. 7(1). 180–180. 15 indexed citations

Vanova, Katerina Hadrava, Rachael N. Labitt, Juan Ye, et al.. (2024). Role of B cells in intratumoral MBTA immunotherapy of murine pheochromocytoma model. Best Practice & Research Clinical Endocrinology & Metabolism. 39(1). 101941–101941. 2 indexed citations

Polanská, Hana, Barbora Papoušková, Michal Hendrych, et al.. (2023). Safety assessment and redox status in rats after chronic exposure to cannabidiol and cannabigerol. Toxicology. 488. 153460–153460. 10 indexed citations

Raudenská, Martina, et al.. (2023). Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(5). 188940–188940. 19 indexed citations

Kejík, Zdeněk, Robert Kaplánek, Kateřina Veselá, et al.. (2022). New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity. Pharmaceutics. 14(8). 1712–1712. 4 indexed citations

10.

Kejík, Zdeněk, Robert Kaplánek, Kateřina Veselá, et al.. (2022). Non-psychotropic cannabinoids as inhibitors of TET1 protein. Bioorganic Chemistry. 124. 105793–105793. 10 indexed citations

11.

Jakubek, Milan, Michal Masařík, Tomáš Břı́za, et al.. (2021). PPO-Inhibiting Herbicides and Structurally Relevant Schiff Bases: Evaluation of Inhibitory Activities against Human Protoporphyrinogen Oxidase. Processes. 9(2). 383–383. 8 indexed citations

12.

Kejík, Zdeněk, Robert Kaplánek, Petr Dytrych, et al.. (2021). Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design. Pharmaceutics. 13(11). 1879–1879. 18 indexed citations

13.

Raudenská, Martina, et al.. (2020). Metabolic and Amino Acid Alterations of the Tumor Microenvironment. Current Medicinal Chemistry. 28(7). 1270–1289. 20 indexed citations

14.

Gumulec, Jaromír, et al.. (2018). Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis. Scientific Reports. 8(1). 10370–10370. 20 indexed citations

15.

Dostálová, Simona, Hana Polanská, Markéta Svobodová, et al.. (2018). Prostate-Specific Membrane Antigen-Targeted Site-Directed Antibody-Conjugated Apoferritin Nanovehicle Favorably Influences In Vivo Side Effects of Doxorubicin. Scientific Reports. 8(1). 8867–8867. 28 indexed citations

16.

Raudenská, Martina, Jaromír Gumulec, Petr Babula, et al.. (2013). Haloperidol Cytotoxicity and Its Relation to Oxidative Stress. Mini-Reviews in Medicinal Chemistry. 13(14). 1993–1998. 47 indexed citations

17.

Gumulec, Jaromír, Michal Masařík, Soňa Křížková, et al.. (2011). Evaluation ofalpha-methylacyl-CoA racemase, metallothionein and prostate specific antigen as prostate cancer prognostic markers. Neoplasma. 59(2). 191–201. 24 indexed citations

18.

Babula, Petr, et al.. (2010). Pharmaceutical importance of zinc and metallothionein in cell signalling. 28(6). 18–21. 12 indexed citations

19.

Cernei, Natalia, Michal Masařík, Jaromír Gumulec, et al.. (2010). Determination of sarcosine as possible tumour marker of prostate tumours. Journal Of Biochemical Technology. 2(5). 7–8. 1 indexed citations

20.

Masařík, Michal, et al.. (2009). Detection of metallothionein and alpha-methylacyl CoA racemaseas potential new markers for prostate carcinoma. International Journal of Molecular Medicine. 24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact